Mirae Asset Global Etfs Holdings Ltd. Eledon Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $56.2 Billion
- Q3 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 27,583 shares of ELDN stock, worth $48,546. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,583
Previous 32,052
13.94%
Holding current value
$48,546
Previous $86,000
17.44%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ELDN
# of Institutions
92Shares Held
34.2MCall Options Held
0Put Options Held
360K-
Bvf Inc San Francisco, CA6.29MShares$11.1 Million0.88% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.04MShares$7.11 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.57MShares$6.28 Million0.16% of portfolio
-
Siren, L.L.C. New York, NY2.07MShares$3.65 Million0.21% of portfolio
-
Zimmer Partners, LP New York, NY1.83MShares$3.21 Million0.13% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $24.2M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...